Eiko Lifesciences
Eiko Lifesciences (EIKO) share price was ₹48.67 at the 28 Oct 2026 close; market capitalisation ₹71.29 Cr; P/E (TTM) 13.95; sector Chemicals. The share price fell 4.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 56.4% year on year to ₹16.75 Cr and net profit was ₹1.51 Cr, against ₹1.11 Cr a year earlier (compared with Jun 2025). Promoters held 39.96% of Eiko Lifesciences in Sep 2026, up 0.05 percentage points from Jun 2026. Its Tapetide Score is 58/100 (Good) as of 28 Oct 2026.
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of 29 Oct 2026, 09:49 IST · EPS basis: Consolidated · TTM
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,369.90 | 52.65 | 1,39,439 Cr | 12.88 | 1.48% | 22.36% | 28.48% | 15,689 Cr | 2,677 Cr | |
| ₹4,251.40 | 77.19 | 46,702 Cr | 5.98 | 0.07% | 7.25% | 10.13% | 5,334 Cr | 600 Cr | |
| ₹8,362.50 | 54.28 | 42,893 Cr | 10.80 | 0.18% | 16.70% | 18.66% | 3,734 Cr | 789 Cr | |
| ₹1,575.00 | 88.83 | 20,905 Cr | 8.51 | 0.00% | 8.94% | 12.15% | 1,257 Cr | 235 Cr | |
| ₹1,482.00 | 25.81 | 20,213 Cr | 3.46 | 0.52% | 9.38% | 10.85% | 8,624 Cr | 784 Cr | |
| ₹458.30 | 31.30 | 16,618 Cr | 2.79 | 0.23% | 7.04% | 8.53% | 9,040 Cr | 531 Cr | |
| ₹5,155.00 | 19.66 | 15,177 Cr | 2.31 | 0.55% | 10.95% | 13.54% | 7,185 Cr | 788 Cr | |
| Eiko Lifesciences (this company) | ₹50.65 | 14.51 | 74 Cr | 1.12 | 0.00% | 7.63% | 10.07% | 60 Cr | 6 Cr |
| Median 8 companies | ₹1,528.50 | 41.98 | 20,559 Cr | 4.72 | 0.21% | 9.16% | 11.50% | 6,260 Cr | 692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 98/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Stock is trading at 0.99 times its book value
- Company is expected to give good quarter
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 39.9%
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 11.52% · Jun 2026
Quarterly Results
| Particulars | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.2 | 0.62 | 0.56 | 0.84 | 10.75 | 8.16 | 7.49 | 11.27 | 10.71 | 11.67 | 11.98 | 18.34 | 16.75 |
| Expenses | 4.55 | 1.53 | 0.42 | 0.89 | 10.35 | 7.73 | 6.86 | 9.95 | 9.2 | 9.9 | 10.1 | 16.08 | 14.82 |
| Operating Profit | -1.35 | -0.91 | 0.14 | -0.05 | 0.4 | 0.43 | 0.63 | 1.32 | 1.51 | 1.77 | 1.88 | 2.26 | 1.93 |
| OPM % | -42.19% | -146.77% | 25% | -5.95% | 3.72% | 5.27% | 8.41% | 11.71% | 14.1% | 15.17% | 15.69% | 12.32% | 11.52% |
| Other Income | 0.01 | -0.04 | 0.05 | 0.01 | 0.26 | 0.13 | 0.12 | 0.64 | 0.27 | 0.3 | 0.35 | 0.13 | 0.45 |
| Interest | 0.08 | 0.03 | 0.01 | 0.1 | 0.03 | 0.04 | 0.03 | 0.07 | 0.05 | 0.1 | 0.07 | 0.12 | 0.13 |
| Depreciation | 0.05 | 0.05 | 0.04 | 0.04 | 0.17 | 0.16 | 0.16 | 0.25 | 0.25 | 0.26 | 0.26 | 0.25 | 0.25 |
| PBT | -1.47 | -1.03 | 0.14 | -0.18 | 0.46 | 0.36 | 0.56 | 1.64 | 1.48 | 1.71 | 1.9 | 2.02 | 2 |
| Tax % | -25.85% | -28.16% | 28.57% | -22.22% | 26.09% | 27.78% | 25% | 23.78% | 25% | 24.56% | 24.74% | 25.74% | 24.5% |
| Net Profit | -1.08 | -0.74 | 0.1 | -0.13 | 0.37 | 0.28 | 0.42 | 1.25 | 1.11 | 1.29 | 1.43 | 1.5 | 1.51 |
| EPS (₹) | -0.92 | -0.64 | 0.09 | -0.08 | 0.3 | 0.22 | 0.33 | 0.84 | 0.66 | 0.79 | 0.88 | 0.91 | 0.91 |
Profit & Loss
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 2.36 | 4.27 | 10.4 | 37.66 | 52.57 | 58.74 |
| Expenses | 1.98 | 4.95 | 14.91 | 34.89 | 45.24 | 50.9 |
| Operating Profit | 0.38 | -0.68 | -4.51 | 2.77 | 7.33 | 7.84 |
| OPM % | 16.1% | -15.93% | -43.37% | 7.36% | 13.94% | 13.35% |
| Other Income | 0.04 | 0.04 | 0.01 | 1.2 | 1.16 | 1.23 |
| Interest | 0.09 | 0.19 | 0.24 | 0.17 | 0.36 | 0.42 |
| Depreciation | 0.08 | 0.17 | 0.19 | 0.74 | 1.02 | 1.02 |
| PBT | 0.25 | -1 | -4.93 | 3.06 | 7.11 | 7.63 |
| Tax % | 20% | -21% | -26.77% | 24.51% | 25.18% | — |
| Net Profit | 0.2 | -0.78 | -3.62 | 2.32 | 5.32 | 5.73 |
| EPS (₹) | 0.31 | -0.69 | -2.98 | 1.86 | 3.71 | 3.49 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 3.82 | 3.82 | 3.82 | 13.76 | 14.35 |
| Reserves | 1.74 | 1.1 | -0.87 | 43.03 | 54.44 |
| Borrowings | 1.74 | 1.37 | 1.61 | 2.76 | 4.73 |
| Other Liabilities | 3.66 | 3.01 | 7.49 | 6.56 | 15.85 |
| Total Liabilities | 10.96 | 9.3 | 12.05 | 66.11 | 89.37 |
| Fixed Assets | 1.68 | 1.71 | 1.75 | 23.12 | 22.1 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 3.17 | 1.72 | 0.1 | 7.15 | 15.29 |
| Other Assets | 6.11 | 5.87 | 10.2 | 35.84 | 51.98 |
| Total Assets | 10.96 | 9.3 | 12.05 | 66.11 | 89.37 |
Cash Flow
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 0 | 0.16 | -0.33 | 2.78 | 2.25 |
| Investing | 0 | -0.3 | -0.71 | -11.3 | -8.63 |
| Financing | 0 | -0.55 | 0.95 | 6.96 | 8.21 |
| Net Cash Flow | 0 | -0.69 | -0.09 | -1.57 | 1.83 |
| Free Cash Flow | 0 | -0.04 | -0.56 | -7.51 | 2.25 |
| CFO/OP | 0 | -26 | 7 | 112 | 50 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 226 | 73.51 | 41.41 | 105 | 140 |
| Inventory Days | 820 | 288 | 154 | 64.48 | 35.09 |
| Days Payable | 606 | 174 | 185 | 36.99 | 111 |
| Cash Conversion Cycle | 440 | 187 | 10.72 | 132 | 64.46 |
| Working Capital Days | 80.42 | -1.71 | -152 | 144 | 128 |
| ROCE % | — | -11.83% | -105.39% | — | 11.12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Eiko Lifesciences insights
64 extracted metrics + investor summaries across FY12–FY27.
Documents
Frequently Asked Questions about Eiko Lifesciences
What does Eiko Lifesciences Ltd do?
Where is Eiko Lifesciences Ltd (EIKO) listed?
Which sector does Eiko Lifesciences Ltd belong to?
What is the market capitalisation of Eiko Lifesciences Ltd?
What is the PE ratio of Eiko Lifesciences Ltd?
What is the 52-week high and low of Eiko Lifesciences Ltd?
What is the Return on Equity (ROE) of Eiko Lifesciences Ltd?
Company Information
Incorporated in 2021, Eiko LifeSciences Ltd manufacturing & sells Specialty Chemical and Fine Chemicals[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540204.md for Eiko Lifesciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.